180 related articles for article (PubMed ID: 10500195)
1. CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage.
Reid RJ; Fiorani P; Sugawara M; Bjornsti MA
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11440-5. PubMed ID: 10500195
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of DNA topoisomerase I-induced cell killing in the yeast Saccharomyces cerevisiae.
Fiorani P; Bjornsti MA
Ann N Y Acad Sci; 2000; 922():65-75. PubMed ID: 11193926
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinating enzyme Doa4p protects cells from DNA topoisomerase I poisons.
Fiorani P; Reid RJ; Schepis A; Jacquiau HR; Guo H; Thimmaiah P; Benedetti P; Bjornsti MA
J Biol Chem; 2004 May; 279(20):21271-81. PubMed ID: 14990574
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle arrest and cell death.
Megonigal MD; Fertala J; Bjornsti MA
J Biol Chem; 1997 May; 272(19):12801-8. PubMed ID: 9139740
[TBL] [Abstract][Full Text] [Related]
5. SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I.
Kauh EA; Bjornsti MA
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6299-303. PubMed ID: 7603986
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.
Furuta T; Takemura H; Liao ZY; Aune GJ; Redon C; Sedelnikova OA; Pilch DR; Rogakou EP; Celeste A; Chen HT; Nussenzweig A; Aladjem MI; Bonner WM; Pommier Y
J Biol Chem; 2003 May; 278(22):20303-12. PubMed ID: 12660252
[TBL] [Abstract][Full Text] [Related]
7. Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.
Pouliot JJ; Robertson CA; Nash HA
Genes Cells; 2001 Aug; 6(8):677-87. PubMed ID: 11532027
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.
Rao VA; Fan AM; Meng L; Doe CF; North PS; Hickson ID; Pommier Y
Mol Cell Biol; 2005 Oct; 25(20):8925-37. PubMed ID: 16199871
[TBL] [Abstract][Full Text] [Related]
9. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
Eng WK; Faucette L; Johnson RK; Sternglanz R
Mol Pharmacol; 1988 Dec; 34(6):755-60. PubMed ID: 2849043
[TBL] [Abstract][Full Text] [Related]
10. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
Hsiang YH; Lihou MG; Liu LF
Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
[TBL] [Abstract][Full Text] [Related]
11. Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.
Bjornsti MA; Knab AM; Benedetti P
Cancer Chemother Pharmacol; 1994; 34 Suppl():S1-5. PubMed ID: 8070016
[TBL] [Abstract][Full Text] [Related]
12. Dpb11 protein helps control assembly of the Cdc45·Mcm2-7·GINS replication fork helicase.
Dhingra N; Bruck I; Smith S; Ning B; Kaplan DL
J Biol Chem; 2015 Mar; 290(12):7586-601. PubMed ID: 25659432
[TBL] [Abstract][Full Text] [Related]
13. Multiple endonucleases function to repair covalent topoisomerase I complexes in Saccharomyces cerevisiae.
Deng C; Brown JA; You D; Brown JM
Genetics; 2005 Jun; 170(2):591-600. PubMed ID: 15834151
[TBL] [Abstract][Full Text] [Related]
14. Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I.
Colley WC; van der Merwe M; Vance JR; Burgin AB; Bjornsti MA
J Biol Chem; 2004 Dec; 279(52):54069-78. PubMed ID: 15489506
[TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA.
Nitiss JL; Wang JC
Mol Pharmacol; 1996 Nov; 50(5):1095-102. PubMed ID: 8913340
[TBL] [Abstract][Full Text] [Related]
17. Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast.
Reid RJ; Kauh EA; Bjornsti MA
J Biol Chem; 1997 May; 272(18):12091-9. PubMed ID: 9115278
[TBL] [Abstract][Full Text] [Related]
18. CDC45, a novel yeast gene that functions with the origin recognition complex and Mcm proteins in initiation of DNA replication.
Zou L; Mitchell J; Stillman B
Mol Cell Biol; 1997 Feb; 17(2):553-63. PubMed ID: 9001208
[TBL] [Abstract][Full Text] [Related]
19. Mcm10 and Cdc45 cooperate in origin activation in Saccharomyces cerevisiae.
Sawyer SL; Cheng IH; Chai W; Tye BK
J Mol Biol; 2004 Jul; 340(2):195-202. PubMed ID: 15201046
[TBL] [Abstract][Full Text] [Related]
20. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.
Knab AM; Fertala J; Bjornsti MA
J Biol Chem; 1995 Mar; 270(11):6141-8. PubMed ID: 7890748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
